FDA (Drugs) recall action 65690
The FDA (Drugs) publishes a recall like this one as 265 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 265 pages.
Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.
Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug: ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014.
Labeling: Label Mixup: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD60272_16, EXP: 5/22/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 65162066810, Pedigree: AD73646_13, EXP: 5/30/2014.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Aidapak Services is recalling Losartan Potassium 50 mg tablets because they may have been mislabeled as Atorvastatin Calcium 80 mg.
Aidapak Services, LLC is recalling 5 mg rosuvastatin calcium tablets because they may have been mislabeled as ibuprofen or ascorbic acid.
Aidapak Services, LLC is recalling 403 tablets of Pyridoxine HCL 50 mg because they may have been mislabeled as other medications. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services is recalling Venlafaxine HCL 75 mg tablets because they may have been mislabeled as Tacrolimus capsules.
Aidapak Services is recalling Mycophenolate Mofetil capsules because they may have been mislabeled as Atorvastatin or Propranolol.
Aidapak Services is recalling Valsartan 320 mg tablets because they may have been mislabeled as Cilostazol 100 mg.
Aidapak Services, LLC is recalling 50 mg Pyridoxine HCL tablets because they may have been mislabeled as other medications. The affected products were distributed in four western states.
Aidapak Services, LLC is recalling Bumetanide 1 mg tablets that may have been mislabeled as Guaifenesin ER 600 mg. The error could lead to incorrect medication administration.
Aidapak Services, LLC is recalling glyBURIDE tablets because they may have been mislabeled as CYPROHEPTADINE HCL or AMANTADINE HCL.
Aidapak Services is recalling 909 tablets of Hyoscyamine Sulfate SL 0.125 mg because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Buprenorphine HCL SL tablets due to a potential label mixup with other medications.
Aidapak Services, LLC is recalling Isoniazid 300 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Albuterol Sulfate ER 4 mg tablets that may have been mislabeled as Simvastatin 20 mg.
Aidapak Services, LLC is recalling Niacin 100 mg tablets that may be mislabeled as GuaiFENesin ER 600 mg. The recall covers repacked drugs distributed in four western states.
Aidapak Services is recalling 2.5 mg Bromocriptine Mesylate tablets that may have been mislabeled as 200 mg Caffeine tablets.
Aidapak Services, LLC is recalling Losartan Potassium 50 mg tablets because they may have been mislabeled as Midodrine HCL 2.5 mg.
Aidapak Services is recalling Efavirenz 600 mg tablets because they may have been mislabeled as Niacin ER 500 mg.
Aidapak Services, LLC is recalling Phenol Lozenges because they may have been mislabeled as Atorvastatin Calcium or Vitamin B Complex W/C tablets.
Aidapak Services, LLC is recalling 5 mg Escitalopram tablets because they may have been mislabeled as Sodium Chloride tablets.
Aidapak Services is recalling Guanfacine HC tablets because they may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Hydrochlorothiazide 12.5 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Anagrelide HCL capsules because they may have been mislabeled as Aripiprazole tablets.
Aidapak Services, LLC is recalling Bismuth Subsalicylate chewable tablets that may have been mislabeled as Irbesartan. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling 1,109 docusate calcium capsules because they may have been mislabeled as other medications. The affected products were distributed in four western states.
Aidapak Services, LLC is recalling Clindamycin HCL capsules because they may have been mislabeled as Melatonin tablets. The repacked drugs were distributed in four western states.